SGRY

$12.65

Pre-MarketAs of Mar 17, 8:00 PM UTC

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$12.65
Potential Upside
5%
Whystock Fair Value$13.28
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency su...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.64B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
2.76%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.37

Recent News

Simply Wall St.
Mar 12, 2026

Surgery Partners (SGRY) Is Down 9.7% After Soft 2026 Outlook And New Buyback Plan - Has The Bull Case Changed?

Surgery Partners recently reported fourth-quarter and full-year 2025 results showing higher sales but continued net losses, issued softer 2026 revenue guidance of US$3.35 billion to US$3.45 billion, launched a new US$200 million share repurchase authorization, and continued expanding its outpatient footprint with the acquisition of Preferred Vascular Group. These updates, combined with insider share sales to cover tax obligations and an activist investor push for board and portfolio changes,...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 12, 2026

3 Small-Cap Stocks with Warning Signs

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 12, 2026

Ortelius Targets Surgery Partners Governance While Shares Screen As Undervalued

Ortelius Advisors has issued an open letter to Surgery Partners (NasdaqGS:SGRY) calling for major changes to the board and management team. The activist investor cites destruction of stockholder value and urges a reassessment of the company’s direction. The campaign brings public pressure on Surgery Partners’ leadership and puts potential corporate governance changes on the table. Surgery Partners operates a network of surgical facilities, positioning it within the outpatient and ambulatory...

BEARISH
Negative press. News cycle fixated on risk factors or misses.
StockStory
Mar 9, 2026

Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY)

Let’s dig into the relative performance of Surgery Partners (NASDAQ:SGRY) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 5, 2026

3 Russell 2000 Stocks with Questionable Fundamentals

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.